Search

for
Search:

Glossary Erlotinib

medication that inhibits cancer cell growth by targeting EGFR

Erlotinib is a medication used to treat certain types of cancer, such as non-small cell lung cancer and pancreatic cancer. It works by inhibiting the epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By blocking this receptor, erlotinib can help slow down or stop the progression of the disease.

Related Terms

Research

5 / 299 results

research Persistent hair growth during treatment with the EGFR inhibitor erlotinib

39 citations , March 2009 in “Dermatology Online Journal”

This review observes that trichomegaly, a newly described side effect of EGFR inhibitors causing excessive eyelash and scalp hair growth, persists in some patients whose tumors respond positively to the therapy.

research A case report of inflammatory nonscarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib

33 citations , June 2009 in “Journal of Cutaneous Pathology”

This article discusses the cutaneous side effects of erlotinib, an EGFR inhibitor, in a patient with non-small cell lung cancer, reporting nonscarring alopecia and indicative scalp biopsy findings.